These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 28210082)

  • 1. Multitarget stool DNA tests increases colorectal cancer screening among previously noncompliant Medicare patients.
    Prince M; Lester L; Chiniwala R; Berger B
    World J Gastroenterol; 2017 Jan; 23(3):464-471. PubMed ID: 28210082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Effectiveness and Cost Effectiveness of a Multitarget Stool DNA Test to Screen for Colorectal Neoplasia.
    Ladabaum U; Mannalithara A
    Gastroenterology; 2016 Sep; 151(3):427-439.e6. PubMed ID: 27311556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults.
    Sharma T
    Public Health; 2020 May; 182():70-76. PubMed ID: 32179290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Patient Adherence to Stool-Based Colorectal Cancer Screening and Colonoscopy Following a Positive Test on Clinical Outcomes.
    Fendrick AM; Fisher DA; Saoud L; Ozbay AB; Karlitz JJ; Limburg PJ
    Cancer Prev Res (Phila); 2021 Sep; 14(9):845-850. PubMed ID: 34021023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multitarget Stool DNA Screening in Clinical Practice: High Positive Predictive Value for Colorectal Neoplasia Regardless of Exposure to Previous Colonoscopy.
    Eckmann JD; Ebner DW; Bering J; Kahn A; Rodriguez E; Devens ME; Lowrie KL; Doering K; Then S; Burger KN; Mahoney DW; Prichard DO; Wallace MB; Gurudu SR; Finney LJ; Limburg P; Berger B; Ahlquist DA; Kisiel JB
    Am J Gastroenterol; 2020 Apr; 115(4):608-615. PubMed ID: 32068535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Performance of Multitarget Stool DNA and CT Colonography for Noninvasive Colorectal Cancer Screening.
    Pickhardt PJ; Graffy PM; Weigman B; Deiss-Yehiely N; Hassan C; Weiss JM
    Radiology; 2020 Oct; 297(1):120-129. PubMed ID: 32779997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Adoption of a Multitarget Stool DNA Test for Colorectal Cancer Screening.
    Finney Rutten LJ; Jacobson RM; Wilson PM; Jacobson DJ; Fan C; Kisiel JB; Sweetser S; Tulledge-Scheitel SM; St Sauver JL
    Mayo Clin Proc; 2017 May; 92(5):726-733. PubMed ID: 28473037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Postcolonoscopy Colorectal Neoplasia by Multi-target Stool DNA.
    Ebner DW; Eckmann JD; Burger KN; Mahoney DW; Bering J; Kahn A; Rodriguez EA; Prichard DO; Wallace MB; Kane SV; Finney Rutten LJ; Gurudu SR; Kisiel JB
    Clin Transl Gastroenterol; 2021 Jun; 12(6):e00375. PubMed ID: 34140458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of multitarget stool DNA testing in African American patients.
    Cooper GS; Markowitz SD; Chen Z; Tuck M; Willis JE; Berger BM; Brenner DE; Li L
    Cancer; 2018 Oct; 124(19):3876-3880. PubMed ID: 30193399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-Effectiveness of Multitarget Stool DNA Testing vs Colonoscopy or Fecal Immunochemical Testing for Colorectal Cancer Screening in Alaska Native People.
    Redwood DG; Dinh TA; Kisiel JB; Borah BJ; Moriarty JP; Provost EM; Sacco FD; Tiesinga JJ; Ahlquist DA
    Mayo Clin Proc; 2021 May; 96(5):1203-1217. PubMed ID: 33840520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPV and Detection Rate of mt-sDNA Testing, FIT, and CT Colonography for Advanced Neoplasia: A Hierarchic Bayesian Meta-Analysis of the Noninvasive Colorectal Screening Tests.
    Pickhardt PJ; Correale L; Hassan C
    AJR Am J Roentgenol; 2021 Oct; 217(4):817-830. PubMed ID: 33703913
    [No Abstract]   [Full Text] [Related]  

  • 12. A novel multitarget stool DNA test for colorectal cancer screening.
    Malik P
    Postgrad Med; 2016; 128(2):268-72. PubMed ID: 26753807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthcare costs, resource utilization, and productivity loss associated with colorectal cancer screening.
    Engel-Nitz NM; Miller-Wilson LA; Le L; Fisher DA
    Expert Rev Pharmacoecon Outcomes Res; 2023; 23(7):843-852. PubMed ID: 37462667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Projecting total costs and health consequences of increasing mt-sDNA utilization for colorectal cancer screening from the payer and integrated delivery network perspectives.
    Hathway JM; Miller-Wilson LA; Jensen IS; Ozbay B; Regan C; Jena AB; Weinstein MC; Parks PD
    J Med Econ; 2020 Jun; 23(6):581-592. PubMed ID: 32063100
    [No Abstract]   [Full Text] [Related]  

  • 15. Colorectal Neoplasia Detection in Individuals With Positive Multitarget Stool DNA Tests: Data From the New Hampshire Colonoscopy Registry.
    Anderson JC; Robinson CM; Hisey WM; Edwards DK; Kneedler BL; Berger BM; Butterly LF
    J Clin Gastroenterol; 2022 May-Jun 01; 56(5):419-425. PubMed ID: 33973962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity of the Multi-Target Stool DNA Test for Colorectal Cancer Screening in Average-Risk 45-49 Year-Olds: A Cross-Sectional Study.
    Imperiale TF; Kisiel JB; Itzkowitz SH; Scheu B; Duimstra EK; Statz S; Berger BM; Limburg PJ
    Cancer Prev Res (Phila); 2021 Apr; 14(4):489-496. PubMed ID: 33436397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of Colorectal Cancer Risk Factors on Predictive Value of a Positive Multitarget Stool DNA Test.
    Narayani KR; Narayani RI
    J Clin Gastroenterol; 2024 May-Jun 01; 58(5):471-474. PubMed ID: 37389965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alaska Native Patient and Provider Perspectives on the Multitarget Stool DNA Test Compared With Colonoscopy for Colorectal Cancer Screening.
    Redwood DG; Blake ID; Provost EM; Kisiel JB; Sacco FD; Ahlquist DA
    J Prim Care Community Health; 2019; 10():2150132719884295. PubMed ID: 31646933
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection of High-Risk Sessile Serrated Lesions: Multitarget Stool DNA Versus CT Colonography.
    Deiss-Yehiely N; Graffy PM; Weigman B; Hassan C; Matkowskyj KA; Pickhardt PJ; Weiss JM
    AJR Am J Roentgenol; 2022 Apr; 218(4):670-676. PubMed ID: 34755523
    [No Abstract]   [Full Text] [Related]  

  • 20. Multi-target stool DNA test in the surveillance of inflammatory bowel disease: a cross-sectional cohort study.
    Klepp P; Kisiel JB; Småstuen MC; Røseth A; Andersen SN; Vatn MH; Ahlquist DA; Moum BA; Brackmann S
    Scand J Gastroenterol; 2018 Mar; 53(3):273-278. PubMed ID: 29313389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.